BIOMENTEK AS

7336 MELDAL

Finances

Return on Equity

39,19 %

Current Ratio

1,51

Debt-to-Equity Ratio

0,13

Key figures (NOK)	2022	2021	2020	2019
Revenue	33 745 000	22 867 000	16 056 000	14 196 000
Net Income	1 770 000	865 000	233 000	37 000
Total Assets	10 797 000	7 407 000	6 053 000	5 078 000
Total Equity	4 516 000	3 245 000	2 380 000	2 147 000

Income (NOK)	2022	2021	2020	2019
Revenue	33 745 000	22 867 000	16 056 000	14 196 000
Expenditure	31 976 000	21 637 000	15 651 000	14 053 000
Operating Profit	2 270 000	1 229 000	405 000	143 000
Financial Income	0	0	0	0
Financial Costs	65 000	142 000	106 000	96 000
Financial Balance	−65 000	−142 000	−106 000	−96 000
Earnings Before Tax	2 204 000	1 087 000	299 000	48 000
Tax	434 000	222 000	66 000	11 000
Net Income	1 770 000	865 000	233 000	37 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 190 000	1 187 000	1 334 000	841 000
Total Current Assets	8 607 000	6 220 000	4 719 000	4 237 000
Total Assets	10 797 000	7 407 000	6 053 000	5 078 000
Total Retained Equity	3 224 000	1 954 000	1 089 000	855 000
Total Equity	4 516 000	3 245 000	2 380 000	2 147 000
Total Long-Term Debt	586 000	259 000	332 000	0
Total Current Debt	5 696 000	3 903 000	3 341 000	2 931 000
Total Equity and Debt	10 797 000	7 407 000	6 053 000	5 078 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	34 559 000	22 966 000	15 832 000	14 231 000
Other Income	−814 000	−99 000	223 000	−35 000
Revenue	33 745 000	22 867 000	16 056 000	14 196 000
Cost of Goods Sold	23 259 000	16 673 000	11 676 000	10 107 000
Salary Costs	5 811 000	2 824 000	2 582 000	2 590 000
Depreciation	250 000	182 000	183 000	133 000
Impairment	0	0	0	0
Expenditure	31 976 000	21 637 000	15 651 000	14 053 000
Operating Profit	2 270 000	1 229 000	405 000	143 000
Financial Income	0	0	0	0
Financial Costs	65 000	142 000	106 000	96 000
Financial Balance	−65 000	−142 000	−106 000	−96 000
Dividends	500 000	0	0	0
Net Income	1 770 000	865 000	233 000	37 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	51 000	22 000	88 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	486 000	11 000	41 000	83 000
Fixtures	1 201 000	590 000	704 000	220 000
Total Tangible Assets	1 687 000	601 000	744 000	303 000
Total Fiancial Fixed Assets	504 000	536 000	568 000	450 000
Total Fixed Assets	2 190 000	1 187 000	1 334 000	841 000
Stock	1 786 000	1 352 000	1 205 000	872 000
Total Investments	0	0	0	0
Cash, Bank	2 104 000	2 073 000	705 000	184 000
Total Current Assets	8 607 000	6 220 000	4 719 000	4 237 000
Total Assets	10 797 000	7 407 000	6 053 000	5 078 000
Total Equity	4 516 000	3 245 000	2 380 000	2 147 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	586 000	259 000	332 000	0
Creditors	1 614 000	904 000	557 000	603 000
Unpaid Taxes	1 559 000	888 000	890 000	875 000
Dividends	500 000	0	0	0
Other Current Debt	1 893 000	1 400 000	228 000	313 000
Total Current Debt	5 696 000	3 903 000	3 341 000	2 931 000
Total Equity and Debt	10 797 000	7 407 000	6 053 000	5 078 000

Financial indicators	2022	2021	2020	2019
Return on Equity	39,19 %	26,66 %	9,79 %	1,72 %
Debt-to-Equity Ratio	0,13	0,08	0,14	0
Operating Profit Margin	6,73 %	5,37 %	2,52 %	1,01 %
Current Ratio	1,51	1,59	1,41	1,45
Quick Ratio	2,2	2,44	2,21	2,06
Equity Ratio	0,42	0,44	0,39	0,42
Gross Profit Margin	31,07 %	27,09 %	27,28 %	28,8 %